RxDoctor Payments Data

Abdul Hameed, MD

Psychiatry · Cairo, NYNPI 1750395331

Payments from drug & device makers

$1,392in general payments, 2019–2025

Across 72 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$595
  • Neurocrine Biosciences, Inc.$237
  • Alkermes, Inc.$204
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$158
  • Johnson & Johnson$63
  • Teva Pharmaceuticals USA, Inc.$36
  • plus $100 from 4 others

What the payments were for

  • Food & beverage$1,392100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,392 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$35,586
Medicare patients
67
Services billed
385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl14$25,247
Risperdal ConstaRisperidone Microspheres11$23,524
Aripiprazole36$2,096
Quetiapine Fumarate120$1,265
Hydroxyzine Hcl56$1,177
Trazodone Hcl100$1,023
Mirtazapine84$1,021
Divalproex Sodium ErDivalproex Sodium40$918
Ziprasidone Hcl18$871
Olanzapine33$744
Benztropine Mesylate78$642
Haloperidol43$614
Venlafaxine Hcl ErVenlafaxine Hcl35$605
Duloxetine Hcl54$494
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine19$486

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$595$25,24714 claims
Johnson & JohnsonRisperdal Consta$63$23,52411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Cairo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →